AMCP supports the use of MAC pricing as a managed care tool to encourage the dispensing of cost saving generic drugs and thereby benefiting the overall health care system.
AMCP supports compensation for pharmacists providing direct patient care services. Services provided by pharmacists are a vital part of comprehensive patient care, especially when delivered in collaboration with other health care providers.
Press Release: AMCP CEO Susan A. Cantrell, RPh, CAE, issued the following statement on HHS’s proposed rule to eliminate negotiated rebates for pharmaceuticals under Medicare Part D and managed Medicaid programs.
AMCP sends letter of concern for needed provisions in the Senate amendment in the nature of a substitute of H.R. 6 to Senate leadership and the Chairs and Ranking Members of HELP, Finance, Judiciary, and Commerce committees
AMCP webinar that detailed the Trump Administration’s American Patients First proposal for addressing the rising cost of pharmaceuticals.
AMCP webinar that detailed the Trump Administration’s American Patients First proposal for addressing the rising cost of pharmaceuticals.
Press Release: AMCP CEO Susan A. Cantrell, RPh, CAE, Responds to President Trump’s Speech on Lowering Drug Costs
The Centers for Medicare and Medicaid Services (CMS), will allow for certain MTM activities and fraud reduction activities to count toward Medicare Part D and Medicare Advantage medical loss ratio (MLR)
